Mechanisms of Macrophage Activation

巨噬细胞激活机制

基本信息

  • 批准号:
    6789253
  • 负责人:
  • 金额:
    $ 28.76万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-08-15 至 2008-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The contribution of mononuclear phagocytes in host response to cancer is determined in large part through the pattern of gene expression induced in response to stimuli encountered in the tumor microenvironment. Control of macrophage gene expression in response to prototypic pro-inflammatory (IFNgamma and LPS) or anti-inflammatory agents (IL-10 and TGFbeta) results from the integration of multiple intracellular signals that operate at both transcriptional and post-transcriptional levels. Current knowledge of post-transcriptional regulation of specific mRNA stability is limited. AU rich sequence elements (AREs) in the 3' untranslated regions (UTRs) of many cytokine and chemokine mRNAs in concert with ARE-specific RNA binding proteins lead to rapid mRNA decay. We and others have shown that pro-inflammatory or anti-inflammatory stimuli can stabilize or destabilize, respectively, selected chemokine mRNAs particularly KC (mouse CXCL1). These findings lead to the general hypothesis that post-transcriptional control of transiently expressed inflammatory genes involves the induced stabilization of unstable mRNAs through a process that operates in sequence specific fashion. Anti-inflammatory agents act by antagonizing this response. At present multiple features of this model remain undefined. These include (a) the sequence determinants for stimulus-dependent response, (b) how signaling pathways initiated by stabilizing and/or destabilizing agents are integrated and coupled with control of mRNA stability, (c) which steps in mRNA decay are altered by stabilizing or destabilizing stimuli and (d) how ARE-binding proteins couple signaling events to effector mechanisms responsible for the changes in mRNA decay. We now propose to address these issues as a further test of the hypothesis by performance of the following specific experimental aims. 1. Evaluate the sequence basis for ARE-dependent, stimulus-mediated control of mRNA stability. 2. Evaluate signaling pathways involved in the control of mRNA stability by LPS, IL-10 and TGFbeta. 3. Identify the mRNA decay mechanisms that are subject to stimulus-dependent modulation. 4. Determine the role of known ARE/RNA binding proteins in LPS-induced stabilization and IL-10 or TGFbeta-mediated destabilization
描述(由申请人提供):单核吞噬细胞在宿主对癌症的反应中的贡献很大程度上是通过响应肿瘤微环境中遇到的刺激而诱导的基因表达模式来确定的。响应原型促炎剂(IFNγ 和 LPS)或抗炎剂(IL-10 和 TGFbeta)而控制巨噬细胞基因表达是由在转录和转录后水平上起作用的多个细胞内信号的整合产生的。目前对特定 mRNA 稳定性转录后调控的了解有限。许多细胞因子和趋化因子 mRNA 的 3' 非翻译区 (UTR) 中的所有丰富序列元件 (ARE) 与 ARE 特异性 RNA 结合蛋白共同导致 mRNA 快速衰减。我们和其他人已经证明,促炎或抗炎刺激可以分别稳定或破坏选定的趋化因子 mRNA,特别是 KC(小鼠 CXCL1)。这些发现引出了一个普遍的假设,即瞬时表达炎症基因的转录后控制涉及通过以序列特异性方式运行的过程诱导不稳定 mRNA 的稳定。抗炎剂通过拮抗这种反应来发挥作用。目前该模型的多个功能仍未定义。这些包括(a)刺激依赖性反应的序列决定因素,(b)稳定剂和/或去稳定剂引发的信号传导途径如何整合并与mRNA稳定性的控制相结合,(c)稳定或去稳定刺激改变mRNA衰变的哪些步骤,以及(d)ARE结合蛋白如何将信号传导事件与负责mRNA衰变变化的效应器机制耦合。我们现在建议通过执行以下具体实验目标来解决这些问题,作为对假设的进一步检验。 1. 评估 ARE 依赖性、刺激介导的 mRNA 稳定性控制的序列基础。 2. 评估 LPS、IL-10 和 TGFbeta 控制 mRNA 稳定性所涉及的信号通路。 3. 确定受刺激依赖性调节的 mRNA 衰减机制。 4. 确定已知 ARE/RNA 结合蛋白在 LPS 诱导的稳定和 IL-10 或 TGFbeta 介导的不稳定中的作用

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

THOMAS A. HAMILTON其他文献

THOMAS A. HAMILTON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('THOMAS A. HAMILTON', 18)}}的其他基金

IL-17-driven mechanisms for tumor progression and resistance to therapies
IL-17 驱动的肿瘤进展和治疗耐药机制
  • 批准号:
    10704232
  • 财政年份:
    2022
  • 资助金额:
    $ 28.76万
  • 项目类别:
Core B: Animal Model and Immunotyping Core
核心 B:动物模型和免疫分型核心
  • 批准号:
    10704234
  • 财政年份:
    2022
  • 资助金额:
    $ 28.76万
  • 项目类别:
STAT6 and IL-4/IL-13 Dependent Gene Expression
STAT6 和 IL-4/IL-13 依赖性基因表达
  • 批准号:
    6942226
  • 财政年份:
    2004
  • 资助金额:
    $ 28.76万
  • 项目类别:
Mechanisms of Macrophage Activation
巨噬细胞激活机制
  • 批准号:
    6577347
  • 财政年份:
    2003
  • 资助金额:
    $ 28.76万
  • 项目类别:
Mechanisms of Macrophage Activation
巨噬细胞激活机制
  • 批准号:
    6922790
  • 财政年份:
    2003
  • 资助金额:
    $ 28.76万
  • 项目类别:
Mechanisms of Macrophage Activation
巨噬细胞激活机制
  • 批准号:
    7114396
  • 财政年份:
    2003
  • 资助金额:
    $ 28.76万
  • 项目类别:
Mechanisms of Macrophage Activation
巨噬细胞激活机制
  • 批准号:
    7237249
  • 财政年份:
    2003
  • 资助金额:
    $ 28.76万
  • 项目类别:
Regulation of Chemokine Expression In Vivo
体内趋化因子表达的调节
  • 批准号:
    7068463
  • 财政年份:
    2002
  • 资助金额:
    $ 28.76万
  • 项目类别:
Regulation of Chemokine Expression In Vivo
体内趋化因子表达的调节
  • 批准号:
    6640235
  • 财政年份:
    2002
  • 资助金额:
    $ 28.76万
  • 项目类别:
Regulation of Chemokine Expression In Vivo
体内趋化因子表达的调节
  • 批准号:
    6932383
  • 财政年份:
    2002
  • 资助金额:
    $ 28.76万
  • 项目类别:

相似海外基金

Development of inhibitor evaluation system for channel proteins based on cell-free system
基于无细胞系统的通道蛋白抑制剂评价系统的开发
  • 批准号:
    19K05815
  • 财政年份:
    2019
  • 资助金额:
    $ 28.76万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Autonomous genome replication and protein synthesis in a cell-free system under microfluidic accumulation and feeding (P08)
微流控积累和补给下无细胞系统中的自主基因组复制和蛋白质合成(P08)
  • 批准号:
    405567376
  • 财政年份:
    2018
  • 资助金额:
    $ 28.76万
  • 项目类别:
    CRC/Transregios
Technical developmet of drug discovery basis using cell-free system and nanodisc
无细胞系统和纳米盘药物发现基础的技术进展
  • 批准号:
    16K13096
  • 财政年份:
    2016
  • 资助金额:
    $ 28.76万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Basic technology development for Shark nanobody using antigen protein produced by wheat cell-free system
利用小麦无细胞系统产生的抗原蛋白进行鲨鱼纳米抗体基础技术开发
  • 批准号:
    26640130
  • 财政年份:
    2014
  • 资助金额:
    $ 28.76万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
A cell-free system of Xenopus eggs that induces transcriptional reprogramming
诱导转录重编程的爪蟾卵无细胞系统
  • 批准号:
    26650005
  • 财政年份:
    2014
  • 资助金额:
    $ 28.76万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Synthesis of [18F]labelled proteins using cell-free system
使用无细胞系统合成[18F]标记蛋白质
  • 批准号:
    24790527
  • 财政年份:
    2012
  • 资助金额:
    $ 28.76万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Cell Free System for Identification of MHC Class II Immunodominant Epitopes
用于鉴定 MHC II 类免疫显性表位的无细胞系统
  • 批准号:
    8300254
  • 财政年份:
    2011
  • 资助金额:
    $ 28.76万
  • 项目类别:
Development of activation technology for cell-free system under microwave irradiation
微波辐射下无细胞系统活化技术的研究进展
  • 批准号:
    23655146
  • 财政年份:
    2011
  • 资助金额:
    $ 28.76万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Regulation assay of light dependent transcription using a cell-free system derived from Arabidopsis
使用源自拟南芥的无细胞系统进行光依赖性转录的调控测定
  • 批准号:
    20510188
  • 财政年份:
    2008
  • 资助金额:
    $ 28.76万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
MUTIDIMENSIONAL DIFFUSION EXPERIMENTS IN A CELL-FREE SYSTEM
无细胞系统中的多维扩散实验
  • 批准号:
    7420534
  • 财政年份:
    2006
  • 资助金额:
    $ 28.76万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了